Study to Evaluate the Combination of Bendamustine, Bortezomib and Dexamethasone (BBD) in the First-Line Treatment of Patients With Multiple Myeloma Who Are Not Candidates for High Dose Chemotherapy
Clinical trial NCT01056276 · COMPLETED
Trial details
- NCT number
- NCT01056276
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2015-08-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.